Skip to main content
. Author manuscript; available in PMC: 2015 Feb 3.
Published in final edited form as: Vaccine. 2013 Dec 14;32(6):693–699. doi: 10.1016/j.vaccine.2013.11.098

Table 1.

Participants, Intervals, per-protocol windows and activity by visit

Visit Activity Intention to treat (n) Day Allowable per protocol window Per protocol (n)
Standard Dosing Schedule

 1 Blood draw, Dose 1 109 0 - 109
 2 Dose 2 108 60 days after Dose 1 51–70 days after Dose 1 103
 3 Dose 3 107 183 days after Dose 1 174–193 days after Dose 1 87
 4 Post Dose 3 blood draw 107 30 days after Dose 3 14–49 days after Dose 3 87

Alternate Dosing Schedule

 1 Blood draw, Dose 1 111 0 - 111
 2 Dose 2 110 60 days after Dose 1 51–70 days after Dose 1 110
 3 Dose 3 101 365 days after Dose 1 356–375 days after Dose 1 94
 4 Post Dose 3 blood draw 97 30 days after Dose 3 14–49 days after Dose 3 88